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Summary
The diagnosis of eosinophilic esophagitis (EoE) is based on 
the clinical symptoms of esophageal dysfunction and histopatho-
logical findings of esophageal eosinophilia.1,2 In fact, the clinical, 
endoscopic, and histopathological characteristics of EoE and gas-
troesophageal reflux disease (GERD) overlap substantially, and 
differentiating the two can be difficult.1 Recently, Dellon et al1 
suggested that tissue biomarkers of eosinophil activation or in-
flammation were useful for diagnosing EoE, especially for differ-
entiating it from GERD.1 They performed immunohistochemis-
try for major basic protein (MBP), eotaxin-3, leukotriene A4 hy-
drolase (LTA4H) and leukotriene C4 synthase (LTC4S) in 
esophageal biopsy tissues from EoE and GERD patients and 
demonstrated that patients with EoE had much higher levels of 
MBP and eotaxin-3 in the esophageal epithelium than did GERD 
patients, while there were no differences in LTA4H and 
LTC4S.1 They evaluated the diagnostic utility of MBP and eo-
taxin-3 using receiver operating characteristic curves, and found 
that the combination of MBP and eotaxin-3 staining and the eo-
sinophil numbers nearly completely predicted EoE status with-
out considering other clinical, endoscopic or histopathological 
characteristics.1
The authors concluded that staining for MBP and eotaxin-3 
might improve the current EoE diagnostic standards by adding a 
measure of eosinophil activity, especially for differentiating it 
from GERD.1
Comment
The diagnosis of EoE is based on clinical symptoms and en-
doscopic and histopathological findings. That is, suspicion based 
on clinical symptoms and endoscopy is important for determining 
when to perform an esophageal biopsy to diagnose EoE. Howe-
ver, esophageal eosinophilia, presumably the histopathological 
hallmark of EoE, is frequently seen in esophageal biopsies in 
GERD.3-5 Therefore, it might be important to find other bio-
markers for differentiating EoE from GERD.
The pathogenesis of EoE involves an immunological re-
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sponse to allergen exposure, such as Th2 response. This stim-
ulates esophageal epithelial cells to produce eotaxin-3, which 
leads to eosinophil activation and the release of intracellular gran-
ules, including MBP.6,7 Other allergic proinflammatory media-
tors are involved, including the enzymes LTA4H and LTC4S.8,9 
Therefore, these might be useful biomarkers for diagnosing EoE 
and differentiating it from GERD, as the authors mentioned.1 
Pathophysiologically, the expression of MBP, eotaxin-3, and al-
lergic proinflammatory mediators is upregulated in EoE.10,11 
However, in this study, the correlation between eotaxin-3 density 
and eosinophil count was weaker (r = 0.25) than between MBP 
and eosinophil count even after considering for the different age 
distribution in the case and control groups unlike the previous 
studies. It may be necessary to investigate further why eotaxin-3 
density did not correlate strongly with eosinophil count different 
from MBP.
It is important to determine whether upregulated expressions 
of MBP, eotaxin-3 and allergic proinflammatory mediators are 
clinically useful for determining the diagnosis or prognosis. 
Therefore, this study is valuable for investigating the diagnostic 
utility of these markers, focusing, in particular, on the differential 
diagnosis of GERD. Furthermore, this is a notable study which 
examined the diagnostic utility of MBP and eotaxin-3 in EoE 
with receiver operating characteristic analysis. Quantitative im-
munohistochemistry is a more available method to be used in the 
clinical field than other protein or mRNA measurements.
However, the diagnostic markers might be more useful for 
differentiating EoE from GERD, than for the diagnosis of EoE 
itself, as the authors mentioned, because there are definite diag-
nostic criteria for EoE, such as the eosinophil count. Conse-
quently, it is important to define a study population that is clin-
ically ambiguous in terms of EoE and GERD. In this study, the 
authors analyzed the following subgroups: (1) a GERD group 
with erosive esophagitis only, (2) a GERD group with ≥ 15 eo-
sinophils per high power field on esophageal biopsy, and (3) an 
EoE group with < 100 eosinophils per high power field on 
esophageal biopsy. No data for analyses involving more ambig-
uous subgroups were shown in the manuscript. However, it 
would have been better to show the data for such subgroup analy-
ses because the results might have more relevance for clinically 
ambiguous groups in terms of GERD and EoE.
Furthermore, an analysis of more ambiguous subgroups 
might be helpful for differentiation between EoE and GERD. 
For example, a comparison between EoE and GERD both with 
normal endoscopic findings, or between EoE and GERD both 
with erosive esophagitis, or between proton pump inhibitor re-
sponsive EoE and GERD; that is, subgroups that are difficult to 
differentiate clinically or endoscopically. We hoped that this 
study would have suggested specific criteria for using MBP or 
eotaxin-3 to differentiate EoE from GERD. Nevertheless, this 
study presents valuable data on diagnostic biomarkers of EoE.
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